Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients

INTRODUCTION: suPAR is the soluble form of the urokinase plasminogen activator receptor (uPAR), which is expressed in various immunologically active cells. High suPAR serum concentrations are suggested to reflect the activation of the immune system in circumstances of inflammation and infection, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Koch, Alexander, Voigt, Sebastian, Kruschinski, Carsten, Sanson, Edouard, Dückers, Hanna, Horn, Andreas, Yagmur, Eray, Zimmermann, Henning, Trautwein, Christian, Tacke, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3221996/
https://www.ncbi.nlm.nih.gov/pubmed/21324198
http://dx.doi.org/10.1186/cc10037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3221996/
https://www.ncbi.nlm.nih.gov/pubmed/21324198
http://dx.doi.org/10.1186/cc10037

Ejemplares similares